Back to Search
LIA GARRY, M.D.
M.D.
Emergency Medicine Physician
NPI: 1952832479IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
282208(MA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
EASTERN VIRGINIA MEDICAL SCHOOL
Class of 2017
Research & Publications (14)
Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2.
PMID 19188384·Antimicrob Agents Chemother·2009
8-other
Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths.
PMID 19165319·PLoS Genet·2009
8-other
Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
PMID 17714489·FEMS Immunol Med Microbiol·2007
7-preclinical
Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis.
PMID 16189091·Antimicrob Agents Chemother·2005
4-observational
Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
PMID 15907455·FEMS Immunol Med Microbiol·2005
4-observational
Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin.
PMID 14982811·Antimicrob Agents Chemother·2004
7-preclinical
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.
PMID 14576110·Antimicrob Agents Chemother·2003
7-preclinical
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
PMID 12760890·Antimicrob Agents Chemother·2003
7-preclinical
Impact of elements containing glycopeptide resistance genes on expression of virulence in Enterococcus faecalis peritonitis: a pilot study with rats.
PMID 12709322·Antimicrob Agents Chemother·2003
7-preclinical
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
PMID 12183272·Antimicrob Agents Chemother·2002
7-preclinical
Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
PMID 11257041·Antimicrob Agents Chemother·2001
7-preclinical
Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis.
PMID 11036016·Antimicrob Agents Chemother·2000
7-preclinical
Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.
PMID 10898678·Antimicrob Agents Chemother·2000
7-preclinical
Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.
PMID 10770747·Antimicrob Agents Chemother·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 LAKE AVE N
WORCESTER, MA 01655 - Phone
- (508) 421-1400
Quick Facts
- NPI
- 1952832479
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 14
Are you this provider?
Claim Your Profile